Connecticut is not backing down in its opposition to a judge’s approval last month of OxyContin maker Purdue Pharma’s settlement plan, while the Stamford-based company is still at least two months away from bankruptcy.
The state has now appealed to Judge Colleen McMahon in the U.S. District Court for the Southern District of New York. The appeal reflects his objection to Judge Robert Drain’s September 1 confirmation in bankruptcy court of Purdue’s settlement framework, which would resolve several thousand lawsuits alleging the company fueled the opioid crisis with deceptive marketing of OxyContin and ultimately dissolve the business.
- A look at options for structuring small businesses: South Florida Caribbean News
- Corporate Compliance @ Tech Deals in Germany – The Compliance Guarantee
- “Our orders must be executed in a genuine spirit,” says Supreme Court
- Secondary burden of proof – extended disclosure obligation under German law – Commentary